Novel bicyclic and tricyclic cannabinergic ligands as therapeutic agents
The endocannabinoid system (ECS) encompasses of cannabinoid receptors CB1 and CB2, their endogenous ligands (endocannabinoids), enzymes, proteins and FAAH-like anandamide transporter (FLAT), involved in endocannabinoid formation, transportation and bio-inactivation.1-3 The ECS is shown to be involve...
| Published: |
|
|---|---|
| Online Access: | http://hdl.handle.net/2047/d20002823 |